Skip to main content
SI logo

Shoulder Innovations, Inc. (SI) Stock: Price, Forecast & Analyst Target

Shoulder Innovations, Inc. (SI) — MoonshotScore 32/100 (Weak band), calculated Oct 4, 2026. Price $19.01 (+1.39%), as of the Oct 2, 2026 trading session; market cap $394M.

Educational signal · not a buy or sell recommendation · How to read this

$19.01 +$0.26 (+1.39%) Market Cap $394M

Shoulder Innovations, Inc. · SI · NYSE

Shoulder Innovations, Inc. specializes in the development and manufacturing of medical devices, particularly a shoulder replacement system.

Price as of Oct 2, 2026

Key Statistics

32 of 100

MoonshotScore v2 · Shoulder Innovations (SI)

Weak
Business Quality Average (40)
Financial Safety Fortress (95)
Valuation Full (48)
Growth Durability Fading (31)
Momentum Rising (76)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

A fortress balance sheet, but weak growth; the market is already moving on it. Business Quality: Average; Financial Safety: Fortress; Valuation: Full; Growth Durability: Fading; Momentum: Rising.

  • quarterly revenue $17M (Q2 FY2026, quarter ended Jun 2026)
  • EPS beat 2 of 5
  • Altman Z 8.08 · Piotroski F 2

Holding back: soft growth

Helping: balance-sheet strength, positive momentum

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for SI (29 recorded, newest six shown)
RecordedScoreBand
32Weak
32Weak
32Weak
32Weak
32Weak
32Weak

The score was 32 in the stored Oct 3, 2026 snapshot and remains 32 in the current publication computed Oct 4, 2026 (0); the largest pillar moves were Business Quality +1 and Momentum -1; the pillar moves offset under the sector-relative weighting, so the headline score is unchanged.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · Educational signal · not a buy or sell recommendation · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$19.01
Change on the day+1.39%
52-week range$10.92 – $24.60
Market capitalisation$394M
Shares traded on the day144.4K

Price & events

Council Score · weighted blend of 2 available disciplines

Council score for Shoulder Innovations (SI): Split View

41/100 · C

Some lenses disagree with the MoonshotScore. Compare their readings below; each uses a different method.

5-Factor Breakdown

Growth Durability Weak
Momentum Moderate
Business Quality Neutral
Financial Safety Strong
Valuation Neutral

Legends Council

4 lenses, 4 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Englander-style lens (simulated) Izzy Englander Neutral read
Klarman-style lens (simulated) Seth Klarman Unfavorable read
Moon AI lens (model) Neutral read

Read on: Oct 4, 2026

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Moderate
Margin of Safety Fairly Valued
Revenue Growth Strong

Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

One of these lenses reads this company more favourably than the MoonshotScore does: Dalio-style lens. Each lens is a separate scoring function over its own inputs, so a disagreement is a difference of method rather than a correction — the page's answer stays the MoonshotScore above.

On Sep 10, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.

Readings on this page are from Oct 5, 2026, except a card that shows its own read date.

Watch the SI film — every key number, told as a short cinematic story

~2 min · open the film

1 · What is it?

What is Shoulder Innovations (SI), and what does it report?

Short answer · as of

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Shoulder Innovations, Inc. (SI) is listed on NYSE. It employs 74 people and is led by Robert Joseph Ball. In Q2 FY2026 it reported revenue of $17M and net income of -$10M. The market values it at $394M.

2 · Latest results

What do the latest results show for Shoulder Innovations (SI)?

Short answer · as of

The most recent reported quarter, Q2 FY2026, carried revenue of $17M. Against analyst estimates the company has EPS beat 2 of 5 reports.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q2 FY2026$17M-$10M-$0.49 (diluted)
Q1 FY2026$17M-$8M-$0.41 (diluted)
Q4 FY2025$14M-$8M-$0.38 (diluted)
Q3 FY2025$12M-$9M-$0.43 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Shoulder Innovations (SI)?

Short answer

The MoonshotScore pillars rate balance-sheet strength, positive momentum as strengths. What is holding it back is soft growth. The distress and quality screens read Altman Z 8.08 · Piotroski F 2. Trailing ratios: ROE -25.7% · ROA -23.0% · current ratio 10.71 · earnings yield -8.9% · free-cash-flow yield -11.9%.

Data-derived red flags

  • Negative return on equity (-25.7%) — the business is not currently generating profit on shareholder capital.
  • Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
4 · What to check next?

What should you watch next at Shoulder Innovations (SI)?

Short answer · as of

Current published price targets run low $19.00 · high $28.00 · consensus $23.50 · median $23.50 against a quoted price of $19.01 (as of Oct 2, 2026).

What the records here don't tell us

  • No forward revenue or earnings estimate is on file.
  • The next earnings date is not yet scheduled in the calendar we read.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does Shoulder Innovations compare with its peers?

Short answer

Shoulder Innovations's score ranks 4th of 4 in the bounded comparison shown, against 3 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Zimmer Biomet Holdings, Inc. (ZBH) Named competitor$88.29 Oct 2, 2026$17.1B80 5-pillar Oct 4, 2026
Stryker Corporation (SYK) Named competitor$275.43 Oct 2, 2026$106B79 5-pillar Oct 4, 2026
Inspira Technologies Oxy B.H.N. Ltd. (QTEX) Same industry, near in market value$1.10 Oct 2, 2026$47.9M44 5-pillar Oct 4, 2026
Shoulder Innovations (SI) — this page$19.01$394M32

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

The records behind this page

Analyst targets & estimates

What analysts have on file

Price target, low to high
$19.00 – $28.00
Consensus target
$23.50
Median target
$23.50

Consensus record · Captured .

Measured against a quoted price of $19.01 (as of Oct 2, 2026).

Insider activity

Form 4 records via FMP · Available records within the last 180 days, newest dated Aug 26, 2026 (coverage not recorded)

Transactions
28
Identified insiders
8
Purchases
0
Sales
16
Other transactions
12

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

What has been published about Shoulder Innovations (SI)?

Read these with our analysis →

Common Questions About SI

These answers are editorial: 1 of these 9 answers is drawn from the SI research dossier (written May 10, 2026 by gemini-2.0-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.

What does the MoonshotScore mean for SI?

SI carries the MoonshotScore stated above — the Weak band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Is SI a good stock to buy?

Stock Expert AI does not rate SI buy, sell or hold. Shoulder Innovations, Inc. carries a MoonshotScore, in the Weak band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the SI stock price today?

The last price recorded on this page for Shoulder Innovations, Inc. (SI) is $19.01, as of the Oct 2, 2026 trading session (source: Financial Modeling Prep (FMP) · quote). It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the SI price target?

The analyst consensus price target for Shoulder Innovations, Inc. (SI) is $23.50 (range $19.00 to $28.00, median $23.50), per FMP data captured Oct 4, 2026. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.

What are the main risks for SI?

Shoulder Innovations, Inc. faces several key risks inherent in the medical device industry. These include competition from larger, more established orthopedic device companies with greater resources, regulatory hurdles and potential delays in obtaining FDA approvals for new products, and the impact of economic downturns on healthcare spending and demand for elective surgeries.

What are the key factors to evaluate for SI?

Shoulder Innovations, Inc. (SI) holds a MoonshotScore in the low range. Analysts target $23.50 (+24%). Not financial advice.

How frequently does SI data refresh on this page?

SI's price is the last quote we recorded, from the Oct 2, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven SI's recent stock price performance?

Shoulder Innovations, Inc. (SI) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Innovative shoulder replacement system. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider SI overvalued or undervalued right now?

Shoulder Innovations, Inc. (SI) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Analysts target $23.50 (+24%) — upside seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources — records for every figure on this page (21 figures)

The 21 rows below are exactly the facts the evidence-backed sections of this page printed — the 10-second verdict, the MoonshotScore, price and market value, the five questions with their receipts, and the records behind this page. Known dates and sources are recorded on their own rows; an em dash or UNRECORDED tier preserves a stored observation without inventing either. The quarterly income statement is provider-standardized (FMP) under one row, and scale definitions — a 0-100 rating, the band ladder, the Piotroski 0–9 range — are fixed rather than measured. No number in those sections was generated by a model. The register does not cover quoted third-party headlines, the dated council readings, or the Frequently Asked Questions; each of those says where it came from where it stands.

"As of" is the date the value is true for where the source carries one — a quarter end, a filing date, a price close, the day the score was computed. A cached observation with no source date remains undated; the page publication date is not used as a substitute.

FMP — 13 facts from Financial Modeling Prep endpoint families

FMP facts used on this page
Fact IDFactValue as shownAs ofTierSource
px.lastLatest provided price$19.01FMPFinancial Modeling Prep (FMP) · quote — Dated to the US trading session the price belongs to, derived from the quote record's timestamp (weekend and pre-open reads roll back to the previous weekday; exchange holidays are not modelled). The record does not establish an exchange execution time. Retrieved 2026-10-04T19:24:43.069Z.
px.changeChange on the day+1.39%FMPFinancial Modeling Prep (FMP) · quote
px.mcapMarket capitalisation$394MFMPFinancial Modeling Prep (FMP) · quote — Date unknown Market cap record date: 2026-10-02. FMP quote timestamp: 2026-10-02T20:00:02.000Z. Captured from FMP at 2026-10-04T19:24:42.174Z. No share-count basis is inferred; this page preserves the reported amount instead of recalculating it from shares.
px.change_absChange on the day, in dollars+$0.26FMPFinancial Modeling Prep (FMP) · quote
fin.q_revenueRevenue, Q2 FY2026$17MFMPFinancial Modeling Prep (FMP) · income statement (quarterly)
px.volumeShares traded on the day144.4KFMPFinancial Modeling Prep (FMP) · quote
fin.q_incomeNet income, Q2 FY2026-$10MFMPFinancial Modeling Prep (FMP) · income statement (quarterly)
fin.q_tableQuarterly income statement4 quarters through Q2 FY2026FMPFinancial Modeling Prep (FMP) · income statement (quarterly), as filed
earn.ptStored analyst price targetslow $19.00 · high $28.00 · consensus $23.50 · median $23.50FMPFinancial Modeling Prep (FMP) · price-target consensus — Captured Oct 4, 2026 · Coverage not supplied
earn.pt_rangeAnalyst price target, low to high$19.00 – $28.00FMPFinancial Modeling Prep (FMP) · price-target consensus — Captured Oct 4, 2026 · Coverage not supplied
earn.pt_consensusConsensus analyst price target$23.50FMPFinancial Modeling Prep (FMP) · price-target consensus — Captured Oct 4, 2026 · Coverage not supplied
earn.pt_medianMedian analyst price target$23.50FMPFinancial Modeling Prep (FMP) · price-target consensus — Captured Oct 4, 2026 · Coverage not supplied
own.insidersInsider transactions via FMP28 transactions · 0 purchases, 16 sales, 12 other transactions · 8 identified insiders · available records within the last 180 days, newest dated Aug 26, 2026 (coverage not recorded)FMPFinancial Modeling Prep (FMP), carrying Form 4 transaction records — Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

UNRECORDED — 6 facts from stored observations whose source was not recorded

UNRECORDED facts used on this page
Fact IDFactValue as shownAs ofTierSource
earn.historyReported versus estimated, recent quartersEPS beat 2 of 5UNRECORDEDStored earnings-history observation — Captured 2026-10-01 · Expired observation
fin.scoresDistress and quality screensAltman Z 8.08 · Piotroski F 2UNRECORDEDStored financial-scores observation — Captured 2026-10-04
px.range5252-week range$10.92 – $24.60UNRECORDEDStored company-profile observation — Captured 2026-10-01
id.employeesEmployees74UNRECORDEDStored company-profile observation — Captured 2026-10-01
id.ceoChief executiveRobert Joseph BallUNRECORDEDStored company-profile observation — Captured 2026-10-01
fin.ratiosReturn and yield ratios (trailing twelve months)ROE -25.7% · ROA -23.0% · current ratio 10.71 · earnings yield -8.9% · free-cash-flow yield -11.9%—UNRECORDEDStored key metrics — Date unknown

OURS — 2 facts from Stock Expert AI's own score and rank

OURS facts used on this page
Fact IDFactValue as shownAs ofTierSource
ours.moonshotMoonshotScore v232 of 100 · Weak · pillars 40 / 95 / 48 / 31 / 76OURSStock Expert AI MoonshotScore v2 engine
ours.moonshot_changeMoonshotScore movement32 (stored snapshot Oct 3, 2026) → 32 (current publication computed Oct 4, 2026) (0)OURSStock Expert AI current score publication and immutable score snapshots
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.